Glooko

This morning Glooko also announced that its diasend platform will be compatible with the Dexcom G6. 

The pharma company will also partner with Dexcom, Glooko, Roche and IBM Watson Health to help patients manage diabetes data.

The FDA has granted Isreal-based DreaMed Diabetes a de novo request for its artificial intelligence-powered software for providers managing patients with Type 1 diabetes.

Glooko announced the launch of the new version of its Glooko Web Application platform this morning.

A free tool against substance abuse.

Digital diabetes management company Glooko announced today that Russ Johannesson will succeed Rick Altinger as the company’s new CEO.

A six-month pilot program conducted by Sharp Rees-Stealy Medical Group in San Diego found that diabetes patients using Glooko’s care management platform were more engaged with their care and achieved better control of their blood glucose levels, according to a case study released by the company.

Digital diabetes care company Glooko announced today that its Mobile Insulin Dosing System (MIDS) — an app-driven tool that recommends insulin dose adjustments using data collected directly from a patient’s blood glucose meter — has been cleared by the FDA.

Health enterprise SaaS company Welltok announced an expanded partnership with IBM Watson Health.

Mountain View, California-based Glooko is collaborating with Danish pharmaceutical company Novo Nordisk to develop a digital diabetes management platform.